Article
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.
The Journal of antimicrobial chemotherapy - 1 Feb 2002
Avison Matthew B, Bennett Peter M, Howe Robin A, Walsh Timothy R
Abstract excerpt
Glycopeptides, such as vancomycin, are frequently the antibiotics of choice for treatment of infections caused by the now common methicillin-resistant Staphylococcus aureus (MRSA). Incidences of vancomycin resistance in S. aureus (VRSA) have been increasing worldwide for the last 5 years. Complex mechanisms producing changes in cell wall content and composition generate the VRSA phenotype, but the genetic basis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
